| Subject: | FDA Issues Notice on Recall of One Lot of Neurontin |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 2 May 2005 - 10:00 am |
| The FDA has notified healthcare professionals that Pfizer Inc., the manufacturer of Neurontin (gabapentin) has voluntarily recalled one lot of this medication. The recalled lot (#15224V) 100 mg capsules contain some bottles with empty or partially filled capsules. Neurontin is prescribed as an analgesic and as an anticonvulsant. Because Neurontin is frequently prescribed to control epilepsy, patients taking the drug to control seizure activity could experience seizures from taking doses that... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
